nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—NR3C1—hematologic cancer	0.102	1	CbGaD
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0704	0.209	CiPCiCtD
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0704	0.209	CiPCiCtD
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.068	0.202	CiPCiCtD
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0658	0.195	CiPCiCtD
Prednicarbate—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0622	0.185	CiPCiCtD
Prednicarbate—Betamethasone—hematologic cancer	0.0513	0.208	CrCtD
Prednicarbate—Dexamethasone—hematologic cancer	0.0513	0.208	CrCtD
Prednicarbate—Triamcinolone—hematologic cancer	0.0501	0.203	CrCtD
Prednicarbate—Prednisone—hematologic cancer	0.0476	0.193	CrCtD
Prednicarbate—Prednisolone—hematologic cancer	0.0464	0.188	CrCtD
Prednicarbate—NR3C1—Triamcinolone—hematologic cancer	0.0224	0.25	CbGbCtD
Prednicarbate—NR3C1—Betamethasone—hematologic cancer	0.0193	0.214	CbGbCtD
Prednicarbate—NR3C1—Prednisolone—hematologic cancer	0.019	0.211	CbGbCtD
Prednicarbate—NR3C1—Prednisone—hematologic cancer	0.0179	0.2	CbGbCtD
Prednicarbate—NR3C1—Dexamethasone—hematologic cancer	0.0112	0.125	CbGbCtD
Prednicarbate—Ciclesonide—Prednisone—hematologic cancer	0.0022	0.0131	CrCrCtD
Prednicarbate—Ciclesonide—Prednisolone—hematologic cancer	0.00215	0.0128	CrCrCtD
Prednicarbate—Difluprednate—Betamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Difluprednate—Dexamethasone—hematologic cancer	0.00199	0.0118	CrCrCtD
Prednicarbate—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00194	0.0116	CrCrCtD
Prednicarbate—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00194	0.0116	CrCrCtD
Prednicarbate—Difluprednate—Triamcinolone—hematologic cancer	0.00194	0.0116	CrCrCtD
Prednicarbate—Beclomethasone—Dexamethasone—hematologic cancer	0.00187	0.0111	CrCrCtD
Prednicarbate—Beclomethasone—Betamethasone—hematologic cancer	0.00187	0.0111	CrCrCtD
Prednicarbate—Testolactone—Betamethasone—hematologic cancer	0.00187	0.0111	CrCrCtD
Prednicarbate—Testolactone—Dexamethasone—hematologic cancer	0.00187	0.0111	CrCrCtD
Prednicarbate—Hydrocortamate—Prednisone—hematologic cancer	0.00184	0.011	CrCrCtD
Prednicarbate—Testolactone—Triamcinolone—hematologic cancer	0.00183	0.0109	CrCrCtD
Prednicarbate—Beclomethasone—Triamcinolone—hematologic cancer	0.00183	0.0109	CrCrCtD
Prednicarbate—Hydrocortamate—Prednisolone—hematologic cancer	0.0018	0.0107	CrCrCtD
Prednicarbate—Cortisone acetate—Prednisone—hematologic cancer	0.00179	0.0106	CrCrCtD
Prednicarbate—Alclometasone—Dexamethasone—hematologic cancer	0.00176	0.0105	CrCrCtD
Prednicarbate—Alclometasone—Betamethasone—hematologic cancer	0.00176	0.0105	CrCrCtD
Prednicarbate—Cortisone acetate—Prednisolone—hematologic cancer	0.00174	0.0104	CrCrCtD
Prednicarbate—Testolactone—Prednisone—hematologic cancer	0.00173	0.0103	CrCrCtD
Prednicarbate—Alclometasone—Triamcinolone—hematologic cancer	0.00172	0.0103	CrCrCtD
Prednicarbate—Budesonide—Dexamethasone—hematologic cancer	0.00172	0.0102	CrCrCtD
Prednicarbate—Budesonide—Betamethasone—hematologic cancer	0.00172	0.0102	CrCrCtD
Prednicarbate—Amcinonide—Dexamethasone—hematologic cancer	0.00172	0.0102	CrCrCtD
Prednicarbate—Amcinonide—Betamethasone—hematologic cancer	0.00172	0.0102	CrCrCtD
Prednicarbate—Testolactone—Prednisolone—hematologic cancer	0.00169	0.0101	CrCrCtD
Prednicarbate—Beclomethasone—Prednisolone—hematologic cancer	0.00169	0.0101	CrCrCtD
Prednicarbate—Budesonide—Triamcinolone—hematologic cancer	0.00168	0.01	CrCrCtD
Prednicarbate—Amcinonide—Triamcinolone—hematologic cancer	0.00168	0.01	CrCrCtD
Prednicarbate—Prednisone—Betamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Flunisolide—Betamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Desonide—Dexamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Clobetasol propionate—Betamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Desonide—Betamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Prednisone—Dexamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Flunisolide—Dexamethasone—hematologic cancer	0.00167	0.00997	CrCrCtD
Prednicarbate—Alclometasone—Prednisone—hematologic cancer	0.00164	0.00975	CrCrCtD
Prednicarbate—Desonide—Triamcinolone—hematologic cancer	0.00163	0.00974	CrCrCtD
Prednicarbate—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00163	0.00974	CrCrCtD
Prednicarbate—Prednisone—Triamcinolone—hematologic cancer	0.00163	0.00974	CrCrCtD
Prednicarbate—Flunisolide—Triamcinolone—hematologic cancer	0.00163	0.00974	CrCrCtD
Prednicarbate—Paramethasone—Dexamethasone—hematologic cancer	0.00163	0.00972	CrCrCtD
Prednicarbate—Paramethasone—Betamethasone—hematologic cancer	0.00163	0.00972	CrCrCtD
Prednicarbate—Alclometasone—Prednisolone—hematologic cancer	0.0016	0.00951	CrCrCtD
Prednicarbate—Paramethasone—Triamcinolone—hematologic cancer	0.00159	0.00949	CrCrCtD
Prednicarbate—Amcinonide—Prednisone—hematologic cancer	0.00159	0.00949	CrCrCtD
Prednicarbate—Budesonide—Prednisone—hematologic cancer	0.00159	0.00949	CrCrCtD
Prednicarbate—Budesonide—Prednisolone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Amcinonide—Prednisolone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Triamcinolone—Betamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Mometasone—Betamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Triamcinolone—Dexamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Loteprednol—Betamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Loteprednol—Dexamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Mometasone—Dexamethasone—hematologic cancer	0.00155	0.00926	CrCrCtD
Prednicarbate—Clobetasol propionate—Prednisone—hematologic cancer	0.00155	0.00924	CrCrCtD
Prednicarbate—Desonide—Prednisone—hematologic cancer	0.00155	0.00924	CrCrCtD
Prednicarbate—Flunisolide—Prednisone—hematologic cancer	0.00155	0.00924	CrCrCtD
Prednicarbate—Dexamethasone—Betamethasone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Rimexolone—Betamethasone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Rimexolone—Dexamethasone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Betamethasone—Dexamethasone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Mometasone—Triamcinolone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Loteprednol—Triamcinolone—hematologic cancer	0.00152	0.00904	CrCrCtD
Prednicarbate—Flunisolide—Prednisolone—hematologic cancer	0.00151	0.00902	CrCrCtD
Prednicarbate—Prednisone—Prednisolone—hematologic cancer	0.00151	0.00902	CrCrCtD
Prednicarbate—Clobetasol propionate—Prednisolone—hematologic cancer	0.00151	0.00902	CrCrCtD
Prednicarbate—Desonide—Prednisolone—hematologic cancer	0.00151	0.00902	CrCrCtD
Prednicarbate—Paramethasone—Prednisone—hematologic cancer	0.00151	0.00901	CrCrCtD
Prednicarbate—Betamethasone—Triamcinolone—hematologic cancer	0.00148	0.00884	CrCrCtD
Prednicarbate—Dexamethasone—Triamcinolone—hematologic cancer	0.00148	0.00884	CrCrCtD
Prednicarbate—Rimexolone—Triamcinolone—hematologic cancer	0.00148	0.00884	CrCrCtD
Prednicarbate—Paramethasone—Prednisolone—hematologic cancer	0.00148	0.00879	CrCrCtD
Prednicarbate—Methylprednisolone—Betamethasone—hematologic cancer	0.00145	0.00865	CrCrCtD
Prednicarbate—Methylprednisolone—Dexamethasone—hematologic cancer	0.00145	0.00865	CrCrCtD
Prednicarbate—Mometasone—Prednisone—hematologic cancer	0.00144	0.00858	CrCrCtD
Prednicarbate—Triamcinolone—Prednisone—hematologic cancer	0.00144	0.00858	CrCrCtD
Prednicarbate—Loteprednol—Prednisone—hematologic cancer	0.00144	0.00858	CrCrCtD
Prednicarbate—Prednisolone—Dexamethasone—hematologic cancer	0.00142	0.00847	CrCrCtD
Prednicarbate—Prednisolone—Betamethasone—hematologic cancer	0.00142	0.00847	CrCrCtD
Prednicarbate—Methylprednisolone—Triamcinolone—hematologic cancer	0.00142	0.00845	CrCrCtD
Prednicarbate—Rimexolone—Prednisone—hematologic cancer	0.00141	0.00839	CrCrCtD
Prednicarbate—Betamethasone—Prednisone—hematologic cancer	0.00141	0.00839	CrCrCtD
Prednicarbate—Dexamethasone—Prednisone—hematologic cancer	0.00141	0.00839	CrCrCtD
Prednicarbate—Mometasone—Prednisolone—hematologic cancer	0.00141	0.00838	CrCrCtD
Prednicarbate—Triamcinolone—Prednisolone—hematologic cancer	0.00141	0.00838	CrCrCtD
Prednicarbate—Loteprednol—Prednisolone—hematologic cancer	0.00141	0.00838	CrCrCtD
Prednicarbate—Prednisolone—Triamcinolone—hematologic cancer	0.00139	0.00827	CrCrCtD
Prednicarbate—Betamethasone—Prednisolone—hematologic cancer	0.00137	0.00819	CrCrCtD
Prednicarbate—Rimexolone—Prednisolone—hematologic cancer	0.00137	0.00819	CrCrCtD
Prednicarbate—Dexamethasone—Prednisolone—hematologic cancer	0.00137	0.00819	CrCrCtD
Prednicarbate—Hydrocortisone—Betamethasone—hematologic cancer	0.00136	0.00813	CrCrCtD
Prednicarbate—Hydrocortisone—Dexamethasone—hematologic cancer	0.00136	0.00813	CrCrCtD
Prednicarbate—Methylprednisolone—Prednisone—hematologic cancer	0.00135	0.00802	CrCrCtD
Prednicarbate—Hydrocortisone—Triamcinolone—hematologic cancer	0.00133	0.00794	CrCrCtD
Prednicarbate—Prednisolone—Prednisone—hematologic cancer	0.00132	0.00785	CrCrCtD
Prednicarbate—Methylprednisolone—Prednisolone—hematologic cancer	0.00131	0.00783	CrCrCtD
Prednicarbate—Hydrocortisone—Prednisone—hematologic cancer	0.00127	0.00754	CrCrCtD
Prednicarbate—Hydrocortisone—Prednisolone—hematologic cancer	0.00123	0.00736	CrCrCtD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000668	0.0406	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.000333	0.0202	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.000333	0.0202	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.000333	0.0202	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.00029	0.0176	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.00029	0.0176	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000278	0.0169	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000256	0.0156	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000253	0.0153	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000247	0.015	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000243	0.0147	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000243	0.0147	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000243	0.0147	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000233	0.0141	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.00022	0.0134	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.000202	0.0122	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000196	0.0119	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.00019	0.0115	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000184	0.0112	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.000183	0.0111	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000182	0.011	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.00018	0.0109	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000178	0.0108	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000178	0.0108	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000169	0.0103	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000167	0.0101	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000167	0.0101	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000164	0.00994	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000159	0.00968	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000159	0.00968	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000159	0.00964	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000157	0.00955	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000157	0.00954	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000155	0.00943	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000154	0.00938	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.000151	0.0092	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000148	0.009	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000144	0.00872	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.000136	0.00825	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000133	0.00805	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.000131	0.00796	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000122	0.00741	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.00012	0.00727	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000119	0.00721	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000113	0.00689	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.00011	0.00668	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000109	0.00662	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.000105	0.0064	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000104	0.0063	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000103	0.00625	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	9.69e-05	0.00588	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	9.66e-05	0.00586	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—GATA2—hematologic cancer	9.57e-05	0.00581	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	9.57e-05	0.00581	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	9.19e-05	0.00558	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	9.02e-05	0.00548	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—AR—hematologic cancer	9.01e-05	0.00547	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	9.01e-05	0.00547	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	8.97e-05	0.00545	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	8.71e-05	0.00529	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	8.7e-05	0.00528	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	8.62e-05	0.00523	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	8.28e-05	0.00503	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	8.04e-05	0.00488	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	7.58e-05	0.00461	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—RARA—hematologic cancer	7.54e-05	0.00458	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	7.44e-05	0.00452	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	7.4e-05	0.00449	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	7.31e-05	0.00444	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	7.12e-05	0.00432	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CEBPA—hematologic cancer	7.01e-05	0.00426	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CEBPD—hematologic cancer	7.01e-05	0.00426	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	6.91e-05	0.0042	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	6.91e-05	0.00419	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	6.9e-05	0.00419	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	6.84e-05	0.00416	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	6.8e-05	0.00413	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—NCOR2—hematologic cancer	6.33e-05	0.00384	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	6.2e-05	0.00376	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	6.18e-05	0.00376	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	6.18e-05	0.00376	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	6.14e-05	0.00373	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	5.88e-05	0.00357	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	5.86e-05	0.00356	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—NCOR1—hematologic cancer	5.86e-05	0.00356	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	5.85e-05	0.00355	CbGpPWpGaD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	5.76e-05	0.0035	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	5.67e-05	0.00344	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	5.61e-05	0.00341	CbGpPWpGaD
Prednicarbate—Difluprednate—NR3C1—hematologic cancer	5.59e-05	0.0526	CrCbGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	5.54e-05	0.00336	CbGpPWpGaD
Prednicarbate—Infection—Cladribine—hematologic cancer	5.45e-05	0.00137	CcSEcCtD
Prednicarbate—Paraesthesia—Fludarabine—hematologic cancer	5.45e-05	0.00137	CcSEcCtD
Prednicarbate—Pain—Procarbazine—hematologic cancer	5.3e-05	0.00133	CcSEcCtD
Prednicarbate—Pruritus—Clofarabine—hematologic cancer	5.23e-05	0.00131	CcSEcCtD
Prednicarbate—Pruritus—Daunorubicin—hematologic cancer	5.23e-05	0.00131	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	5.22e-05	0.00317	CbGpPWpGaD
Prednicarbate—Pruritus—Anagrelide—hematologic cancer	5.2e-05	0.00131	CcSEcCtD
Prednicarbate—Pruritus—Pentostatin—hematologic cancer	5.2e-05	0.00131	CcSEcCtD
Prednicarbate—Pain—Bexarotene—hematologic cancer	5.2e-05	0.00131	CcSEcCtD
Prednicarbate—Pain—Dasatinib—hematologic cancer	5.2e-05	0.00131	CcSEcCtD
Prednicarbate—Pain—Fludarabine—hematologic cancer	5.19e-05	0.0013	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	5.15e-05	0.00313	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—STAT5B—hematologic cancer	5.14e-05	0.00312	CbGpPWpGaD
Prednicarbate—Desonide—NR3C1—hematologic cancer	5.13e-05	0.0483	CrCbGaD
Prednicarbate—Urticaria—Busulfan—hematologic cancer	5.08e-05	0.00128	CcSEcCtD
Prednicarbate—Paraesthesia—Nilotinib—hematologic cancer	5.04e-05	0.00127	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	5.03e-05	0.00306	CbGpPWpGaD
Prednicarbate—Paraesthesia—Imatinib—hematologic cancer	5.02e-05	0.00126	CcSEcCtD
Prednicarbate—Oedema—Melphalan—hematologic cancer	5.01e-05	0.00126	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	4.99e-05	0.00303	CbGpPWpGaD
Prednicarbate—Infection—Melphalan—hematologic cancer	4.97e-05	0.00125	CcSEcCtD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.95e-05	0.00301	CbGpPWpGaD
Prednicarbate—Loteprednol—NR3C1—hematologic cancer	4.94e-05	0.0465	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	4.94e-05	0.003	CbGpPWpGaD
Prednicarbate—Paraesthesia—Cladribine—hematologic cancer	4.93e-05	0.00124	CcSEcCtD
Prednicarbate—Urticaria—Procarbazine—hematologic cancer	4.93e-05	0.00124	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	4.92e-05	0.00299	CbGpPWpGaD
Prednicarbate—Pain—Chlorambucil—hematologic cancer	4.91e-05	0.00123	CcSEcCtD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	4.89e-05	0.00297	CbGpPWpGaD
Prednicarbate—Pruritus—Teniposide—hematologic cancer	4.88e-05	0.00123	CcSEcCtD
Prednicarbate—Oedema—Lenalidomide—hematologic cancer	4.87e-05	0.00122	CcSEcCtD
Prednicarbate—Rash—Methoxsalen—hematologic cancer	4.86e-05	0.00122	CcSEcCtD
Prednicarbate—Dermatitis—Methoxsalen—hematologic cancer	4.86e-05	0.00122	CcSEcCtD
Prednicarbate—Infection—Lenalidomide—hematologic cancer	4.84e-05	0.00121	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	4.83e-05	0.00293	CbGpPWpGaD
Prednicarbate—Urticaria—Dasatinib—hematologic cancer	4.83e-05	0.00121	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	4.83e-05	0.00293	CbGpPWpGaD
Prednicarbate—Pain—Nilotinib—hematologic cancer	4.8e-05	0.00121	CcSEcCtD
Prednicarbate—Oedema—Hydroxyurea—hematologic cancer	4.8e-05	0.00121	CcSEcCtD
Prednicarbate—Pain—Imatinib—hematologic cancer	4.78e-05	0.0012	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	4.78e-05	0.0029	CbGpPWpGaD
Prednicarbate—Infection—Hydroxyurea—hematologic cancer	4.77e-05	0.0012	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	4.75e-05	0.00289	CbGpPWpGaD
Prednicarbate—Paraesthesia—Vinblastine—hematologic cancer	4.73e-05	0.00119	CcSEcCtD
Prednicarbate—Rash—Mercaptopurine—hematologic cancer	4.72e-05	0.00119	CcSEcCtD
Prednicarbate—Dermatitis—Mercaptopurine—hematologic cancer	4.72e-05	0.00119	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	4.7e-05	0.00285	CbGpPWpGaD
Prednicarbate—Pain—Cladribine—hematologic cancer	4.69e-05	0.00118	CcSEcCtD
Prednicarbate—Dermatitis contact—Epirubicin—hematologic cancer	4.66e-05	0.00117	CcSEcCtD
Prednicarbate—Rash—Clofarabine—hematologic cancer	4.66e-05	0.00117	CcSEcCtD
Prednicarbate—Rash—Daunorubicin—hematologic cancer	4.66e-05	0.00117	CcSEcCtD
Prednicarbate—Dermatitis—Daunorubicin—hematologic cancer	4.65e-05	0.00117	CcSEcCtD
Prednicarbate—Dermatitis—Clofarabine—hematologic cancer	4.65e-05	0.00117	CcSEcCtD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	4.64e-05	0.00282	CbGpPWpGaD
Prednicarbate—Rash—Pentostatin—hematologic cancer	4.64e-05	0.00116	CcSEcCtD
Prednicarbate—Rash—Anagrelide—hematologic cancer	4.64e-05	0.00116	CcSEcCtD
Prednicarbate—Dermatitis—Pentostatin—hematologic cancer	4.63e-05	0.00116	CcSEcCtD
Prednicarbate—Dermatitis—Anagrelide—hematologic cancer	4.63e-05	0.00116	CcSEcCtD
Prednicarbate—Urticaria—Chlorambucil—hematologic cancer	4.56e-05	0.00115	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	4.53e-05	0.00275	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	4.53e-05	0.00275	CbGpPWpGaD
Prednicarbate—Pruritus—Busulfan—hematologic cancer	4.52e-05	0.00114	CcSEcCtD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	4.51e-05	0.00274	CbGpPWpGaD
Prednicarbate—Pain—Vinblastine—hematologic cancer	4.5e-05	0.00113	CcSEcCtD
Prednicarbate—Paraesthesia—Melphalan—hematologic cancer	4.5e-05	0.00113	CcSEcCtD
Prednicarbate—Oedema—Bortezomib—hematologic cancer	4.48e-05	0.00113	CcSEcCtD
Prednicarbate—Rash—Idarubicin—hematologic cancer	4.47e-05	0.00112	CcSEcCtD
Prednicarbate—Dermatitis—Idarubicin—hematologic cancer	4.47e-05	0.00112	CcSEcCtD
Prednicarbate—Urticaria—Nilotinib—hematologic cancer	4.46e-05	0.00112	CcSEcCtD
Prednicarbate—Infection—Bortezomib—hematologic cancer	4.45e-05	0.00112	CcSEcCtD
Prednicarbate—Oedema—Bleomycin—hematologic cancer	4.45e-05	0.00112	CcSEcCtD
Prednicarbate—Urticaria—Imatinib—hematologic cancer	4.44e-05	0.00111	CcSEcCtD
Prednicarbate—Infection—Bleomycin—hematologic cancer	4.42e-05	0.00111	CcSEcCtD
Prednicarbate—Pruritus—Procarbazine—hematologic cancer	4.39e-05	0.0011	CcSEcCtD
Prednicarbate—Paraesthesia—Lenalidomide—hematologic cancer	4.37e-05	0.0011	CcSEcCtD
Prednicarbate—Urticaria—Cladribine—hematologic cancer	4.36e-05	0.0011	CcSEcCtD
Prednicarbate—Rash—Teniposide—hematologic cancer	4.35e-05	0.00109	CcSEcCtD
Prednicarbate—Dermatitis—Teniposide—hematologic cancer	4.35e-05	0.00109	CcSEcCtD
Prednicarbate—Infection—Vinorelbine—hematologic cancer	4.35e-05	0.00109	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—hematologic cancer	4.31e-05	0.00108	CcSEcCtD
Prednicarbate—Pruritus—Bexarotene—hematologic cancer	4.3e-05	0.00108	CcSEcCtD
Prednicarbate—Pruritus—Dasatinib—hematologic cancer	4.3e-05	0.00108	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	4.3e-05	0.00261	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	4.3e-05	0.00261	CbGpPWpGaD
Prednicarbate—Pruritus—Fludarabine—hematologic cancer	4.29e-05	0.00108	CcSEcCtD
Prednicarbate—Pain—Melphalan—hematologic cancer	4.28e-05	0.00108	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	4.26e-05	0.00258	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—GATA3—hematologic cancer	4.25e-05	0.00258	CbGpPWpGaD
Prednicarbate—Halobetasol Propionate—NR3C1—hematologic cancer	4.24e-05	0.0399	CrCbGaD
Prednicarbate—Hydrocortamate—NR3C1—hematologic cancer	4.24e-05	0.0399	CrCbGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	4.21e-05	0.00256	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	4.19e-05	0.00254	CbGpPWpGaD
Prednicarbate—Cortisone acetate—NR3C1—hematologic cancer	4.17e-05	0.0393	CrCbGaD
Prednicarbate—Pain—Lenalidomide—hematologic cancer	4.16e-05	0.00105	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.15e-05	0.00252	CbGpPWpGaD
Prednicarbate—Infection—Thiotepa—hematologic cancer	4.15e-05	0.00104	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.15e-05	0.00252	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.14e-05	0.00251	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.14e-05	0.00251	CbGpPWpGaD
Prednicarbate—Pain—Hydroxyurea—hematologic cancer	4.11e-05	0.00103	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.07e-05	0.00247	CbGpPWpGaD
Prednicarbate—Pruritus—Chlorambucil—hematologic cancer	4.06e-05	0.00102	CcSEcCtD
Prednicarbate—Oedema—Thalidomide—hematologic cancer	4.04e-05	0.00101	CcSEcCtD
Prednicarbate—NR3C1—Circadian Clock—CREBBP—hematologic cancer	4.03e-05	0.00245	CbGpPWpGaD
Prednicarbate—Rash—Busulfan—hematologic cancer	4.03e-05	0.00101	CcSEcCtD
Prednicarbate—Dermatitis—Busulfan—hematologic cancer	4.03e-05	0.00101	CcSEcCtD
Prednicarbate—Paraesthesia—Bortezomib—hematologic cancer	4.02e-05	0.00101	CcSEcCtD
Prednicarbate—Megestrol acetate—NR3C1—hematologic cancer	4.02e-05	0.0378	CrCbGaD
Prednicarbate—Infection—Thalidomide—hematologic cancer	4.01e-05	0.00101	CcSEcCtD
Prednicarbate—Paraesthesia—Bleomycin—hematologic cancer	3.99e-05	0.001	CcSEcCtD
Prednicarbate—Urticaria—Melphalan—hematologic cancer	3.98e-05	0.000999	CcSEcCtD
Prednicarbate—Pruritus—Nilotinib—hematologic cancer	3.97e-05	0.000998	CcSEcCtD
Prednicarbate—Pruritus—Imatinib—hematologic cancer	3.95e-05	0.000993	CcSEcCtD
Prednicarbate—Budesonide—NR3C1—hematologic cancer	3.94e-05	0.0371	CrCbGaD
Prednicarbate—Amcinonide—NR3C1—hematologic cancer	3.94e-05	0.0371	CrCbGaD
Prednicarbate—Paraesthesia—Vinorelbine—hematologic cancer	3.93e-05	0.000987	CcSEcCtD
Prednicarbate—Rash—Procarbazine—hematologic cancer	3.91e-05	0.000982	CcSEcCtD
Prednicarbate—Dermatitis—Procarbazine—hematologic cancer	3.91e-05	0.000981	CcSEcCtD
Prednicarbate—Pruritus—Cladribine—hematologic cancer	3.88e-05	0.000975	CcSEcCtD
Prednicarbate—Oedema—Carmustine—hematologic cancer	3.88e-05	0.000975	CcSEcCtD
Prednicarbate—Urticaria—Lenalidomide—hematologic cancer	3.87e-05	0.000971	CcSEcCtD
Prednicarbate—Infection—Carmustine—hematologic cancer	3.86e-05	0.000968	CcSEcCtD
Prednicarbate—Oedema—Alitretinoin—hematologic cancer	3.84e-05	0.000966	CcSEcCtD
Prednicarbate—Rash—Bexarotene—hematologic cancer	3.83e-05	0.000963	CcSEcCtD
Prednicarbate—Rash—Dasatinib—hematologic cancer	3.83e-05	0.000963	CcSEcCtD
Prednicarbate—Pain—Bortezomib—hematologic cancer	3.83e-05	0.000962	CcSEcCtD
Prednicarbate—Dermatitis—Dasatinib—hematologic cancer	3.83e-05	0.000962	CcSEcCtD
Prednicarbate—Dermatitis—Bexarotene—hematologic cancer	3.83e-05	0.000962	CcSEcCtD
Prednicarbate—Rash—Fludarabine—hematologic cancer	3.82e-05	0.00096	CcSEcCtD
Prednicarbate—Dermatitis—Fludarabine—hematologic cancer	3.82e-05	0.000959	CcSEcCtD
Prednicarbate—Infection—Alitretinoin—hematologic cancer	3.82e-05	0.000959	CcSEcCtD
Prednicarbate—Pain—Bleomycin—hematologic cancer	3.8e-05	0.000955	CcSEcCtD
Prednicarbate—Oedema—Ifosfamide—hematologic cancer	3.8e-05	0.000954	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	3.79e-05	0.0023	CbGpPWpGaD
Prednicarbate—Infection—Ifosfamide—hematologic cancer	3.78e-05	0.000948	CcSEcCtD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	3.77e-05	0.00229	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	3.75e-05	0.00228	CbGpPWpGaD
Prednicarbate—Paraesthesia—Thiotepa—hematologic cancer	3.75e-05	0.000942	CcSEcCtD
Prednicarbate—Mometasone—NR3C1—hematologic cancer	3.75e-05	0.0353	CrCbGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	3.74e-05	0.00227	CbGpPWpGaD
Prednicarbate—Pain—Vinorelbine—hematologic cancer	3.74e-05	0.00094	CcSEcCtD
Prednicarbate—Oedema—Vincristine—hematologic cancer	3.7e-05	0.00093	CcSEcCtD
Prednicarbate—Rimexolone—NR3C1—hematologic cancer	3.7e-05	0.0349	CrCbGaD
Prednicarbate—Infection—Vincristine—hematologic cancer	3.68e-05	0.000924	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	3.67e-05	0.00223	CbGpPWpGaD
Prednicarbate—Paraesthesia—Thalidomide—hematologic cancer	3.63e-05	0.000911	CcSEcCtD
Prednicarbate—Oedema—Mitoxantrone—hematologic cancer	3.61e-05	0.000906	CcSEcCtD
Prednicarbate—Oedema—Irinotecan—hematologic cancer	3.61e-05	0.000906	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	3.59e-05	0.00218	CbGpPWpGaD
Prednicarbate—Infection—Mitoxantrone—hematologic cancer	3.58e-05	0.0009	CcSEcCtD
Prednicarbate—Infection—Irinotecan—hematologic cancer	3.58e-05	0.0009	CcSEcCtD
Prednicarbate—Pain—Thiotepa—hematologic cancer	3.57e-05	0.000897	CcSEcCtD
Prednicarbate—Urticaria—Bortezomib—hematologic cancer	3.56e-05	0.000894	CcSEcCtD
Prednicarbate—Pruritus—Melphalan—hematologic cancer	3.54e-05	0.00089	CcSEcCtD
Prednicarbate—Rash—Nilotinib—hematologic cancer	3.54e-05	0.00089	CcSEcCtD
Prednicarbate—Dermatitis—Nilotinib—hematologic cancer	3.54e-05	0.000889	CcSEcCtD
Prednicarbate—Urticaria—Bleomycin—hematologic cancer	3.53e-05	0.000887	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	3.53e-05	0.00214	CbGpPWpGaD
Prednicarbate—Rash—Imatinib—hematologic cancer	3.52e-05	0.000885	CcSEcCtD
Prednicarbate—Dermatitis—Imatinib—hematologic cancer	3.52e-05	0.000884	CcSEcCtD
Prednicarbate—Oedema—Gemcitabine—hematologic cancer	3.51e-05	0.000883	CcSEcCtD
Prednicarbate—Beclomethasone—NR3C1—hematologic cancer	3.49e-05	0.0329	CrCbGaD
Prednicarbate—Infection—Gemcitabine—hematologic cancer	3.49e-05	0.000877	CcSEcCtD
Prednicarbate—Paraesthesia—Carmustine—hematologic cancer	3.48e-05	0.000875	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—STAT1—hematologic cancer	3.48e-05	0.00211	CbGpPWpGaD
Prednicarbate—Urticaria—Vinorelbine—hematologic cancer	3.48e-05	0.000873	CcSEcCtD
Prednicarbate—Rash—Cladribine—hematologic cancer	3.46e-05	0.000869	CcSEcCtD
Prednicarbate—Dermatitis—Cladribine—hematologic cancer	3.46e-05	0.000868	CcSEcCtD
Prednicarbate—Pain—Thalidomide—hematologic cancer	3.46e-05	0.000868	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—AR—hematologic cancer	3.45e-05	0.0325	CrCbGaD
Prednicarbate—Paraesthesia—Alitretinoin—hematologic cancer	3.45e-05	0.000867	CcSEcCtD
Prednicarbate—Pruritus—Lenalidomide—hematologic cancer	3.44e-05	0.000865	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	3.42e-05	0.00208	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	3.41e-05	0.00207	CbGpPWpGaD
Prednicarbate—Paraesthesia—Ifosfamide—hematologic cancer	3.41e-05	0.000857	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	3.41e-05	0.00207	CbGpPWpGaD
Prednicarbate—Alclometasone—NR3C1—hematologic cancer	3.4e-05	0.032	CrCbGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3.39e-05	0.00206	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	3.38e-05	0.00205	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	3.34e-05	0.00203	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ZNF552—hematologic cancer	3.33e-05	0.00202	CbGpPWpGaD
Prednicarbate—Paraesthesia—Vincristine—hematologic cancer	3.33e-05	0.000835	CcSEcCtD
Prednicarbate—Urticaria—Thiotepa—hematologic cancer	3.32e-05	0.000834	CcSEcCtD
Prednicarbate—Pain—Carmustine—hematologic cancer	3.32e-05	0.000834	CcSEcCtD
Prednicarbate—Flunisolide—NR3C1—hematologic cancer	3.31e-05	0.0311	CrCbGaD
Prednicarbate—Clobetasol propionate—NR3C1—hematologic cancer	3.31e-05	0.0311	CrCbGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.29e-05	0.002	CbGpPWpGaD
Prednicarbate—Pain—Alitretinoin—hematologic cancer	3.29e-05	0.000826	CcSEcCtD
Prednicarbate—Oedema—Cisplatin—hematologic cancer	3.28e-05	0.000823	CcSEcCtD
Prednicarbate—Paramethasone—NR3C1—hematologic cancer	3.26e-05	0.0307	CrCbGaD
Prednicarbate—Infection—Cisplatin—hematologic cancer	3.25e-05	0.000817	CcSEcCtD
Prednicarbate—Pain—Ifosfamide—hematologic cancer	3.25e-05	0.000816	CcSEcCtD
Prednicarbate—Paraesthesia—Irinotecan—hematologic cancer	3.24e-05	0.000814	CcSEcCtD
Prednicarbate—Paraesthesia—Mitoxantrone—hematologic cancer	3.24e-05	0.000814	CcSEcCtD
Prednicarbate—Ciclesonide—NR3C1—hematologic cancer	3.21e-05	0.0302	CrCbGaD
Prednicarbate—Urticaria—Thalidomide—hematologic cancer	3.21e-05	0.000806	CcSEcCtD
Prednicarbate—Pruritus—Bortezomib—hematologic cancer	3.17e-05	0.000796	CcSEcCtD
Prednicarbate—Pain—Vincristine—hematologic cancer	3.17e-05	0.000796	CcSEcCtD
Prednicarbate—Rash—Melphalan—hematologic cancer	3.16e-05	0.000793	CcSEcCtD
Prednicarbate—Paraesthesia—Gemcitabine—hematologic cancer	3.16e-05	0.000793	CcSEcCtD
Prednicarbate—Dermatitis—Melphalan—hematologic cancer	3.15e-05	0.000792	CcSEcCtD
Prednicarbate—Pruritus—Bleomycin—hematologic cancer	3.15e-05	0.00079	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.13e-05	0.0019	CbGpPWpGaD
Prednicarbate—Pruritus—Vinorelbine—hematologic cancer	3.1e-05	0.000777	CcSEcCtD
Prednicarbate—Pain—Irinotecan—hematologic cancer	3.09e-05	0.000775	CcSEcCtD
Prednicarbate—Pain—Mitoxantrone—hematologic cancer	3.09e-05	0.000775	CcSEcCtD
Prednicarbate—Methylprednisolone—NR3C1—hematologic cancer	3.08e-05	0.029	CrCbGaD
Prednicarbate—Rash—Lenalidomide—hematologic cancer	3.07e-05	0.000771	CcSEcCtD
Prednicarbate—Dermatitis—Lenalidomide—hematologic cancer	3.07e-05	0.00077	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.07e-05	0.00186	CbGpPWpGaD
Prednicarbate—Urticaria—Alitretinoin—hematologic cancer	3.05e-05	0.000767	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.04e-05	0.00185	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.04e-05	0.00184	CbGpPWpGaD
Prednicarbate—Rash—Hydroxyurea—hematologic cancer	3.03e-05	0.00076	CcSEcCtD
Prednicarbate—Dermatitis—Hydroxyurea—hematologic cancer	3.02e-05	0.00076	CcSEcCtD
Prednicarbate—Urticaria—Ifosfamide—hematologic cancer	3.02e-05	0.000758	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	3.01e-05	0.00183	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	3.01e-05	0.00183	CbGpPWpGaD
Prednicarbate—Pain—Gemcitabine—hematologic cancer	3.01e-05	0.000755	CcSEcCtD
Prednicarbate—Infection—Etoposide—hematologic cancer	2.98e-05	0.000749	CcSEcCtD
Prednicarbate—Oedema—Prednisolone—hematologic cancer	2.96e-05	0.000743	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.96e-05	0.0018	CbGpPWpGaD
Prednicarbate—Pruritus—Thiotepa—hematologic cancer	2.96e-05	0.000742	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.94e-05	0.00179	CbGpPWpGaD
Prednicarbate—Paraesthesia—Cisplatin—hematologic cancer	2.94e-05	0.000739	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.93e-05	0.00178	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.91e-05	0.00177	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.91e-05	0.00177	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.9e-05	0.00176	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.87e-05	0.00174	CbGpPWpGaD
Prednicarbate—Urticaria—Mitoxantrone—hematologic cancer	2.87e-05	0.00072	CcSEcCtD
Prednicarbate—Pruritus—Thalidomide—hematologic cancer	2.86e-05	0.000718	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.84e-05	0.00172	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.83e-05	0.00172	CbGpPWpGaD
Prednicarbate—Rash—Bortezomib—hematologic cancer	2.83e-05	0.000709	CcSEcCtD
Prednicarbate—Dermatitis—Bortezomib—hematologic cancer	2.82e-05	0.000709	CcSEcCtD
Prednicarbate—Rash—Bleomycin—hematologic cancer	2.8e-05	0.000704	CcSEcCtD
Prednicarbate—Pain—Cisplatin—hematologic cancer	2.8e-05	0.000704	CcSEcCtD
Prednicarbate—Dermatitis—Bleomycin—hematologic cancer	2.8e-05	0.000703	CcSEcCtD
Prednicarbate—Rash—Vinorelbine—hematologic cancer	2.76e-05	0.000693	CcSEcCtD
Prednicarbate—Dermatitis—Vinorelbine—hematologic cancer	2.76e-05	0.000692	CcSEcCtD
Prednicarbate—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.75e-05	0.00167	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.75e-05	0.00167	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—EP300—hematologic cancer	2.75e-05	0.00167	CbGpPWpGaD
Prednicarbate—Oedema—Triamcinolone—hematologic cancer	2.72e-05	0.000684	CcSEcCtD
Prednicarbate—Pruritus—Alitretinoin—hematologic cancer	2.72e-05	0.000683	CcSEcCtD
Prednicarbate—Infection—Triamcinolone—hematologic cancer	2.7e-05	0.000679	CcSEcCtD
Prednicarbate—Paraesthesia—Etoposide—hematologic cancer	2.69e-05	0.000677	CcSEcCtD
Prednicarbate—Pruritus—Ifosfamide—hematologic cancer	2.69e-05	0.000675	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—ESR1—hematologic cancer	2.66e-05	0.025	CrCbGaD
Prednicarbate—Paraesthesia—Prednisolone—hematologic cancer	2.66e-05	0.000668	CcSEcCtD
Prednicarbate—NR3C1—Adipogenesis—FAS—hematologic cancer	2.64e-05	0.0016	CbGpPWpGaD
Prednicarbate—Rash—Thiotepa—hematologic cancer	2.63e-05	0.000662	CcSEcCtD
Prednicarbate—Dermatitis—Thiotepa—hematologic cancer	2.63e-05	0.000661	CcSEcCtD
Prednicarbate—Triamcinolone—NR3C1—hematologic cancer	2.6e-05	0.0244	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.58e-05	0.00157	CbGpPWpGaD
Prednicarbate—Pain—Etoposide—hematologic cancer	2.57e-05	0.000645	CcSEcCtD
Prednicarbate—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.56e-05	0.00155	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.56e-05	0.00155	CbGpPWpGaD
Prednicarbate—Rash—Thalidomide—hematologic cancer	2.55e-05	0.00064	CcSEcCtD
Prednicarbate—Dermatitis—Thalidomide—hematologic cancer	2.55e-05	0.000639	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.54e-05	0.00154	CbGpPWpGaD
Prednicarbate—Pain—Prednisolone—hematologic cancer	2.53e-05	0.000636	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.52e-05	0.00153	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CASC3—hematologic cancer	2.52e-05	0.00153	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.5e-05	0.00152	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.49e-05	0.00151	CbGpPWpGaD
Prednicarbate—Pruritus—Gemcitabine—hematologic cancer	2.49e-05	0.000624	CcSEcCtD
Prednicarbate—Oedema—Betamethasone—hematologic cancer	2.47e-05	0.00062	CcSEcCtD
Prednicarbate—Oedema—Dexamethasone—hematologic cancer	2.47e-05	0.00062	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.46e-05	0.00149	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.45e-05	0.00149	CbGpPWpGaD
Prednicarbate—Infection—Betamethasone—hematologic cancer	2.45e-05	0.000616	CcSEcCtD
Prednicarbate—Infection—Dexamethasone—hematologic cancer	2.45e-05	0.000616	CcSEcCtD
Prednicarbate—Rash—Carmustine—hematologic cancer	2.45e-05	0.000615	CcSEcCtD
Prednicarbate—Dermatitis—Carmustine—hematologic cancer	2.44e-05	0.000614	CcSEcCtD
Prednicarbate—Paraesthesia—Triamcinolone—hematologic cancer	2.44e-05	0.000614	CcSEcCtD
Prednicarbate—Rash—Alitretinoin—hematologic cancer	2.42e-05	0.000609	CcSEcCtD
Prednicarbate—Dermatitis—Alitretinoin—hematologic cancer	2.42e-05	0.000608	CcSEcCtD
Prednicarbate—Rash—Ifosfamide—hematologic cancer	2.4e-05	0.000602	CcSEcCtD
Prednicarbate—Dermatitis—Ifosfamide—hematologic cancer	2.39e-05	0.000601	CcSEcCtD
Prednicarbate—Urticaria—Etoposide—hematologic cancer	2.38e-05	0.000599	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.37e-05	0.00144	CbGpPWpGaD
Prednicarbate—Prednisone—NR3C1—hematologic cancer	2.36e-05	0.0222	CrCbGaD
Prednicarbate—Urticaria—Prednisolone—hematologic cancer	2.35e-05	0.000591	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	2.34e-05	0.0221	CrCbGaD
Prednicarbate—Rash—Vincristine—hematologic cancer	2.34e-05	0.000587	CcSEcCtD
Prednicarbate—Dermatitis—Vincristine—hematologic cancer	2.33e-05	0.000586	CcSEcCtD
Prednicarbate—Pain—Triamcinolone—hematologic cancer	2.33e-05	0.000585	CcSEcCtD
Prednicarbate—Fluticasone Propionate—NR3C1—hematologic cancer	2.32e-05	0.0219	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.31e-05	0.0014	CbGpPWpGaD
Prednicarbate—Rash—Mitoxantrone—hematologic cancer	2.27e-05	0.000571	CcSEcCtD
Prednicarbate—Rash—Irinotecan—hematologic cancer	2.27e-05	0.000571	CcSEcCtD
Prednicarbate—Dermatitis—Irinotecan—hematologic cancer	2.27e-05	0.000571	CcSEcCtD
Prednicarbate—Dermatitis—Mitoxantrone—hematologic cancer	2.27e-05	0.000571	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.26e-05	0.00138	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.22e-05	0.00135	CbGpPWpGaD
Prednicarbate—Paraesthesia—Betamethasone—hematologic cancer	2.22e-05	0.000557	CcSEcCtD
Prednicarbate—Paraesthesia—Dexamethasone—hematologic cancer	2.22e-05	0.000557	CcSEcCtD
Prednicarbate—Rash—Gemcitabine—hematologic cancer	2.22e-05	0.000557	CcSEcCtD
Prednicarbate—Dermatitis—Gemcitabine—hematologic cancer	2.21e-05	0.000556	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.18e-05	0.00133	CbGpPWpGaD
Prednicarbate—Prednisolone—NR3C1—hematologic cancer	2.17e-05	0.0204	CrCbGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.16e-05	0.00131	CbGpPWpGaD
Prednicarbate—Urticaria—Triamcinolone—hematologic cancer	2.16e-05	0.000543	CcSEcCtD
Prednicarbate—Oedema—Prednisone—hematologic cancer	2.15e-05	0.00054	CcSEcCtD
Prednicarbate—Infection—Prednisone—hematologic cancer	2.14e-05	0.000537	CcSEcCtD
Prednicarbate—Betamethasone—NR3C1—hematologic cancer	2.13e-05	0.02	CrCbGaD
Prednicarbate—Pruritus—Etoposide—hematologic cancer	2.12e-05	0.000533	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.12e-05	0.00129	CbGpPWpGaD
Prednicarbate—Pain—Dexamethasone—hematologic cancer	2.11e-05	0.00053	CcSEcCtD
Prednicarbate—Pain—Betamethasone—hematologic cancer	2.11e-05	0.00053	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.1e-05	0.00127	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.08e-05	0.00126	CbGpPWpGaD
Prednicarbate—Rash—Cisplatin—hematologic cancer	2.07e-05	0.000519	CcSEcCtD
Prednicarbate—Dermatitis—Cisplatin—hematologic cancer	2.06e-05	0.000518	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.05e-05	0.00124	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—RB1—hematologic cancer	2.02e-05	0.00123	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.01e-05	0.00122	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	2.01e-05	0.00122	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	2e-05	0.00121	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.98e-05	0.0012	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.97e-05	0.0012	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.97e-05	0.0012	CbGpPWpGaD
Prednicarbate—Urticaria—Dexamethasone—hematologic cancer	1.96e-05	0.000493	CcSEcCtD
Prednicarbate—Urticaria—Betamethasone—hematologic cancer	1.96e-05	0.000493	CcSEcCtD
Prednicarbate—Megestrol acetate—ABCB1—hematologic cancer	1.94e-05	0.0183	CrCbGaD
Prednicarbate—Paraesthesia—Prednisone—hematologic cancer	1.93e-05	0.000485	CcSEcCtD
Prednicarbate—Pruritus—Triamcinolone—hematologic cancer	1.93e-05	0.000484	CcSEcCtD
Prednicarbate—Hydrocortisone—ABCG2—hematologic cancer	1.93e-05	0.0181	CrCbGaD
Prednicarbate—Rash—Etoposide—hematologic cancer	1.89e-05	0.000475	CcSEcCtD
Prednicarbate—Dermatitis—Etoposide—hematologic cancer	1.89e-05	0.000475	CcSEcCtD
Prednicarbate—Rash—Prednisolone—hematologic cancer	1.87e-05	0.000469	CcSEcCtD
Prednicarbate—Dermatitis—Prednisolone—hematologic cancer	1.86e-05	0.000468	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.8e-05	0.00109	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.79e-05	0.00109	CbGpPWpGaD
Prednicarbate—Infection—Methotrexate—hematologic cancer	1.79e-05	0.000449	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.76e-05	0.00107	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.75e-05	0.00107	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.75e-05	0.00106	CbGpPWpGaD
Prednicarbate—Pruritus—Betamethasone—hematologic cancer	1.75e-05	0.000439	CcSEcCtD
Prednicarbate—Pruritus—Dexamethasone—hematologic cancer	1.75e-05	0.000439	CcSEcCtD
Prednicarbate—Rash—Triamcinolone—hematologic cancer	1.72e-05	0.000431	CcSEcCtD
Prednicarbate—Dermatitis—Triamcinolone—hematologic cancer	1.71e-05	0.000431	CcSEcCtD
Prednicarbate—Urticaria—Prednisone—hematologic cancer	1.71e-05	0.000429	CcSEcCtD
Prednicarbate—Oedema—Epirubicin—hematologic cancer	1.68e-05	0.000422	CcSEcCtD
Prednicarbate—Infection—Epirubicin—hematologic cancer	1.67e-05	0.00042	CcSEcCtD
Prednicarbate—Hydrocortisone—NR3C1—hematologic cancer	1.66e-05	0.0156	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—RARS—hematologic cancer	1.63e-05	0.000987	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.62e-05	0.000984	CbGpPWpGaD
Prednicarbate—Paraesthesia—Methotrexate—hematologic cancer	1.61e-05	0.000405	CcSEcCtD
Prednicarbate—Rash—Dexamethasone—hematologic cancer	1.56e-05	0.000391	CcSEcCtD
Prednicarbate—Rash—Betamethasone—hematologic cancer	1.56e-05	0.000391	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—hematologic cancer	1.56e-05	0.000391	CcSEcCtD
Prednicarbate—Dermatitis—Betamethasone—hematologic cancer	1.56e-05	0.000391	CcSEcCtD
Prednicarbate—Dermatitis—Dexamethasone—hematologic cancer	1.56e-05	0.000391	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—hematologic cancer	1.55e-05	0.000388	CcSEcCtD
Prednicarbate—Pain—Methotrexate—hematologic cancer	1.54e-05	0.000386	CcSEcCtD
Prednicarbate—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.53e-05	0.000928	CbGpPWpGaD
Prednicarbate—Pruritus—Prednisone—hematologic cancer	1.52e-05	0.000382	CcSEcCtD
Prednicarbate—Paraesthesia—Epirubicin—hematologic cancer	1.51e-05	0.000379	CcSEcCtD
Prednicarbate—Methylprednisolone—ABCB1—hematologic cancer	1.49e-05	0.014	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.48e-05	0.000901	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.47e-05	0.000893	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.45e-05	0.000881	CbGpPWpGaD
Prednicarbate—Pain—Epirubicin—hematologic cancer	1.44e-05	0.000361	CcSEcCtD
Prednicarbate—Dexamethasone—ABCG2—hematologic cancer	1.43e-05	0.0135	CrCbGaD
Prednicarbate—Urticaria—Methotrexate—hematologic cancer	1.43e-05	0.000359	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.43e-05	0.000867	CbGpPWpGaD
Prednicarbate—Paraesthesia—Doxorubicin—hematologic cancer	1.4e-05	0.000351	CcSEcCtD
Prednicarbate—Rash—Prednisone—hematologic cancer	1.36e-05	0.000341	CcSEcCtD
Prednicarbate—Dermatitis—Prednisone—hematologic cancer	1.35e-05	0.00034	CcSEcCtD
Prednicarbate—Urticaria—Epirubicin—hematologic cancer	1.34e-05	0.000336	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.33e-05	0.00081	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.33e-05	0.000808	CbGpPWpGaD
Prednicarbate—Pain—Doxorubicin—hematologic cancer	1.33e-05	0.000334	CcSEcCtD
Prednicarbate—NR3C1—Gene Expression—TET2—hematologic cancer	1.33e-05	0.000805	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RARA—hematologic cancer	1.33e-05	0.000805	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.31e-05	0.000794	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.3e-05	0.000789	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.29e-05	0.000786	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.29e-05	0.000785	CbGpPWpGaD
Prednicarbate—Pruritus—Methotrexate—hematologic cancer	1.27e-05	0.000319	CcSEcCtD
Prednicarbate—Dexamethasone—NR3C1—hematologic cancer	1.24e-05	0.0116	CrCbGaD
Prednicarbate—Urticaria—Doxorubicin—hematologic cancer	1.24e-05	0.000311	CcSEcCtD
Prednicarbate—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.23e-05	0.000748	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.23e-05	0.000747	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.22e-05	0.000739	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.21e-05	0.000732	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.2e-05	0.000728	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.19e-05	0.000724	CbGpPWpGaD
Prednicarbate—Prednisone—ALB—hematologic cancer	1.19e-05	0.0112	CrCbGaD
Prednicarbate—Pruritus—Epirubicin—hematologic cancer	1.19e-05	0.000299	CcSEcCtD
Prednicarbate—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.18e-05	0.000714	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ELL—hematologic cancer	1.16e-05	0.000703	CbGpPWpGaD
Prednicarbate—Prednisone—ABCB1—hematologic cancer	1.14e-05	0.0107	CrCbGaD
Prednicarbate—Rash—Methotrexate—hematologic cancer	1.13e-05	0.000285	CcSEcCtD
Prednicarbate—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.13e-05	0.000688	CbGpPWpGaD
Prednicarbate—Dermatitis—Methotrexate—hematologic cancer	1.13e-05	0.000284	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.13e-05	0.000686	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—TNF—hematologic cancer	1.12e-05	0.00068	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.11e-05	0.000675	CbGpPWpGaD
Prednicarbate—Pruritus—Doxorubicin—hematologic cancer	1.1e-05	0.000277	CcSEcCtD
Prednicarbate—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.07e-05	0.000653	CbGpPWpGaD
Prednicarbate—Rash—Epirubicin—hematologic cancer	1.06e-05	0.000266	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—hematologic cancer	1.06e-05	0.000266	CcSEcCtD
Prednicarbate—Prednisolone—ABCB1—hematologic cancer	1.05e-05	0.00986	CrCbGaD
Prednicarbate—Betamethasone—ABCB1—hematologic cancer	1.03e-05	0.00966	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—AGO2—hematologic cancer	1.03e-05	0.000623	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1e-05	0.00061	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—H3F3B—hematologic cancer	1e-05	0.00061	CbGpPWpGaD
Prednicarbate—Rash—Doxorubicin—hematologic cancer	9.81e-06	0.000246	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—hematologic cancer	9.81e-06	0.000246	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	9.68e-06	0.000588	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RPS14—hematologic cancer	9.19e-06	0.000558	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NUP98—hematologic cancer	9.04e-06	0.000549	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IL6—hematologic cancer	9.04e-06	0.000549	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NUP214—hematologic cancer	8.72e-06	0.000529	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	8.44e-06	0.000513	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	8.16e-06	0.000496	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	8.03e-06	0.000488	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HSPB1—hematologic cancer	8.03e-06	0.000488	CbGpPWpGaD
Prednicarbate—Hydrocortisone—ABCB1—hematologic cancer	8.01e-06	0.00754	CrCbGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	7.81e-06	0.000474	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SMC1A—hematologic cancer	7.69e-06	0.000467	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—H3F3A—hematologic cancer	7.54e-06	0.000458	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	7.4e-06	0.000449	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EZH2—hematologic cancer	7.23e-06	0.000439	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PARP1—hematologic cancer	7.08e-06	0.00043	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HDAC2—hematologic cancer	6.83e-06	0.000415	CbGpPWpGaD
Prednicarbate—Dexamethasone—ABCB1—hematologic cancer	5.97e-06	0.00562	CrCbGaD
Prednicarbate—NR3C1—Gene Expression—AR—hematologic cancer	5.92e-06	0.000359	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CDKN2B—hematologic cancer	5.45e-06	0.000331	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NCOR1—hematologic cancer	5.17e-06	0.000314	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	4.39e-06	0.000267	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.14e-06	0.000252	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR1—hematologic cancer	4.06e-06	0.000247	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	3.93e-06	0.000239	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.56e-06	0.000216	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.17e-06	0.000132	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MYC—hematologic cancer	2.11e-06	0.000128	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—AKT1—hematologic cancer	1.47e-06	8.9e-05	CbGpPWpGaD
